Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,763 INR | +1.93% | +1.69% | +4.10% |
05-14 | Transcript : Zydus Wellness Limited, Q4 2024 Earnings Call, May 14, 2024 | |
05-14 | Zydus Wellness Sees Rise in Fiscal Q4 Consolidated Net Profit | MT |
Strengths
- The group's high margin levels account for strong profits.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 36.81 and 27.7 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.7 times its current sales, is high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.10% | 1.31B | - | ||
-2.94% | 274B | A- | ||
-0.69% | 96.48B | C+ | ||
-2.14% | 43.95B | C+ | ||
+12.04% | 42.24B | B- | ||
+1.23% | 41.25B | B- | ||
+8.77% | 40B | B- | ||
-14.61% | 30.49B | B- | ||
-7.18% | 28.7B | A | ||
+14.87% | 25.55B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ZYDUSWELL Stock
- ZYDUSWELL Stock
- Ratings Zydus Wellness Limited